share_log

阿斯利康、罗氏等众多跨国药企持续看好中国市场,加速创新药引进布局

动脉网 ·  Jun 23 10:35

跨国药企如阿斯利康、罗氏等看好中国市场,加速创新药引进布局。多家企业计划在未来几年内引入数十款创新药物,以满足中国老龄化带来的旺盛医药需求,同时国内鼓励创新政策也为创新药发展提供了支持。

The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment